1230118007: Product containing precisely bacitracin 250 unit/1 gram and neomycin sulfate 5 milligram/1 gram and sulfacetamide sodium 60 milligram/1 gram conventional release cutaneous powder (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Product manufactured as cutaneous dose form (product)\Product containing neomycin in cutaneous dose form (medicinal product form)\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Product manufactured as cutaneous dose form (product)\Product containing bacitracin in cutaneous dose form (medicinal product form)\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Product manufactured as cutaneous dose form (product)\Product containing sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder

\Medicinal product categorized by disposition (product)\Product containing bacitracin (medicinal product)\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Medicinal product categorized by disposition (product)\Product containing bacitracin (medicinal product)\Bacitracin- and neomycin- and sulfacetamide-containing product\Product containing only bacitracin and neomycin and sulfacetamide (medicinal product)\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Medicinal product categorized by disposition (product)\Product containing bacitracin (medicinal product)\Product containing bacitracin in cutaneous dose form (medicinal product form)\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Medicinal product categorized by disposition (product)\Product containing neomycin (medicinal product)\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Medicinal product categorized by disposition (product)\Product containing neomycin (medicinal product)\Bacitracin- and neomycin- and sulfacetamide-containing product\Product containing only bacitracin and neomycin and sulfacetamide (medicinal product)\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Medicinal product categorized by disposition (product)\Product containing neomycin (medicinal product)\Product containing neomycin in cutaneous dose form (medicinal product form)\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Medicinal product categorized by disposition (product)\Product containing sulfacetamide (medicinal product)\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Medicinal product categorized by disposition (product)\Product containing sulfacetamide (medicinal product)\Bacitracin- and neomycin- and sulfacetamide-containing product\Product containing only bacitracin and neomycin and sulfacetamide (medicinal product)\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Medicinal product categorized by disposition (product)\Product containing sulfacetamide (medicinal product)\Product containing sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder

\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing peptide (product)\Product containing cyclic peptide (product)\Product containing bacitracin (medicinal product)\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing peptide (product)\Product containing cyclic peptide (product)\Product containing bacitracin (medicinal product)\Bacitracin- and neomycin- and sulfacetamide-containing product\Product containing only bacitracin and neomycin and sulfacetamide (medicinal product)\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing peptide (product)\Product containing cyclic peptide (product)\Product containing bacitracin (medicinal product)\Product containing bacitracin in cutaneous dose form (medicinal product form)\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing sulfonamide (product)\Medicinal product containing sulfonamide and acting as antibacterial agent (product)\Product containing sulfacetamide (medicinal product)\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing sulfonamide (product)\Medicinal product containing sulfonamide and acting as antibacterial agent (product)\Product containing sulfacetamide (medicinal product)\Bacitracin- and neomycin- and sulfacetamide-containing product\Product containing only bacitracin and neomycin and sulfacetamide (medicinal product)\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing sulfonamide (product)\Medicinal product containing sulfonamide and acting as antibacterial agent (product)\Product containing sulfacetamide (medicinal product)\Product containing sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing sulfonamide (product)\Medicinal product containing sulfonamide and acting as antibacterial agent (product)\Product containing sulfacetamide (medicinal product)\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing sulfonamide (product)\Medicinal product containing sulfonamide and acting as antibacterial agent (product)\Product containing sulfacetamide (medicinal product)\Bacitracin- and neomycin- and sulfacetamide-containing product\Product containing only bacitracin and neomycin and sulfacetamide (medicinal product)\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing sulfonamide (product)\Medicinal product containing sulfonamide and acting as antibacterial agent (product)\Product containing sulfacetamide (medicinal product)\Product containing sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Medicinal product categorized by structure\Product containing glycoside (product)\Product containing aminoglycoside (product)\Aminoglycoside antibacterial agent\Product containing neomycin (medicinal product)\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Medicinal product categorized by structure\Product containing glycoside (product)\Product containing aminoglycoside (product)\Aminoglycoside antibacterial agent\Product containing neomycin (medicinal product)\Bacitracin- and neomycin- and sulfacetamide-containing product\Product containing only bacitracin and neomycin and sulfacetamide (medicinal product)\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Medicinal product categorized by structure\Product containing glycoside (product)\Product containing aminoglycoside (product)\Aminoglycoside antibacterial agent\Product containing neomycin (medicinal product)\Product containing neomycin in cutaneous dose form (medicinal product form)\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder

\Medicinal product categorised by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\...

\Aminoglycoside antibacterial agent\Product containing neomycin (medicinal product)\...

\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Bacitracin- and neomycin- and sulfacetamide-containing product\Product containing only bacitracin and neomycin and sulfacetamide (medicinal product)\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder

\Product containing neomycin in cutaneous dose form (medicinal product form)\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder

\Product containing bacitracin (medicinal product)\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Product containing bacitracin (medicinal product)\Bacitracin- and neomycin- and sulfacetamide-containing product\Product containing only bacitracin and neomycin and sulfacetamide (medicinal product)\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Product containing bacitracin (medicinal product)\Product containing bacitracin in cutaneous dose form (medicinal product form)\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder

\Medicinal product containing sulfonamide and acting as antibacterial agent (product)\Product containing sulfacetamide (medicinal product)\...

\Bacitracin- and neomycin- and sulfacetamide-containing product\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
\Bacitracin- and neomycin- and sulfacetamide-containing product\Product containing only bacitracin and neomycin and sulfacetamide (medicinal product)\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder

\Product containing sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form\Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)\Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

5067244011 Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

5067245012 Product containing precisely bacitracin 250 unit/1 gram and neomycin sulfate 5 milligram/1 gram and sulfacetamide sodium 60 milligram/1 gram conventional release cutaneous powder (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

5639481000052112 bacitracin 250 enheter/g, natriumsulfacetamid 60 mg/g och neomycinsulfat 5 mg/g, puder sv Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	Is a	Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)	true	Inferred relationship	Some
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	Has manufactured dose form	Cutaneous powder	true	Inferred relationship	Some
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	Plays role	Antibacterial therapeutic role (role)	true	Inferred relationship	Some
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	Has precise active ingredient	Sulfacetamide sodium	true	Inferred relationship	Some	1
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	Has basis of strength substance (attribute)	Sulfacetamide sodium	true	Inferred relationship	Some	1
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	1
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	Has concentration strength denominator unit	g	true	Inferred relationship	Some	1
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	Has precise active ingredient	Bacitracin	true	Inferred relationship	Some	2
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	Has basis of strength substance (attribute)	Bacitracin	true	Inferred relationship	Some	2
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	Has concentration strength numerator unit	Unit	true	Inferred relationship	Some	2
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	Has concentration strength denominator unit	g	true	Inferred relationship	Some	2
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	Has precise active ingredient	Neomycin sulfate	true	Inferred relationship	Some	3
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	Has basis of strength substance (attribute)	Neomycin sulfate	true	Inferred relationship	Some	3
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	3
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	Has concentration strength denominator unit	g	true	Inferred relationship	Some	3

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Description inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
5067244011	Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
5067245012	Product containing precisely bacitracin 250 unit/1 gram and neomycin sulfate 5 milligram/1 gram and sulfacetamide sodium 60 milligram/1 gram conventional release cutaneous powder (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
5639481000052112	bacitracin 250 enheter/g, natriumsulfacetamid 60 mg/g och neomycinsulfat 5 mg/g, puder	sv	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT Sweden NRC maintained module (core metadata concept)